TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 5.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,500,000 | -39.9% | 537,600 | 0.0% | 0.16% | -35.8% |
| Q3 2016 | $4,161,000 | +27.7% | 537,600 | 0.0% | 0.25% | +27.6% |
| Q2 2016 | $3,258,000 | -28.9% | 537,600 | 0.0% | 0.20% | -22.3% |
| Q1 2016 | $4,580,000 | -28.6% | 537,600 | 0.0% | 0.26% | -20.2% |
| Q4 2015 | $6,414,000 | +69.3% | 537,600 | +43.1% | 0.32% | +45.9% |
| Q3 2015 | $3,788,000 | -15.8% | 375,800 | +38.6% | 0.22% | -9.5% |
| Q2 2015 | $4,498,000 | +58.8% | 271,100 | +48.1% | 0.24% | +14.1% |
| Q1 2015 | $2,833,000 | +15.4% | 183,000 | +18.1% | 0.21% | -20.5% |
| Q4 2014 | $2,455,000 | +48.4% | 155,000 | 0.0% | 0.27% | +16.0% |
| Q3 2014 | $1,654,000 | +30.4% | 155,000 | +14.8% | 0.23% | +34.3% |
| Q2 2014 | $1,268,000 | – | 135,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |